Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 11/28/2021 By Sneha ShahNovember 30, 2021
Leveraged & Inverse Content Hub Top Performing Leveraged/Inverse ETFs: 11/14/2021 By Sneha ShahNovember 17, 2021
Leveraged & Inverse Content Hub This Bearish Biotech ETF Is up 16% in the Past Month By Ben HernandezOctober 12, 2021
Leveraged & Inverse Content Hub Biotech Rose with the Virus. Now It’s Falling Behind By Ben HernandezMarch 19, 2021
Leveraged & Inverse Content Hub Post-Vaccine Distribution, Mergers Will Dominate Biotech Industry ETFs By Ben HernandezNovember 24, 2020
Leveraged & Inverse Content Hub Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Leveraged & Inverse Content Hub A Big Week for Betting On the CURE for Cancer By DirexionJune 8, 2019
Leveraged & Inverse Content Hub Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
Leveraged & Inverse Content Hub After a Rough October, Leveraged Biotech ETF Looks to Bounce Back By Brenton GarenNovember 6, 2018
